Loading...

RCOphth Annual Congress 2026

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 260 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

P156

Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment For Geographic Atrophy Secondary to AMD

Preview of Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment For Geographic Atrophy Secondary to AMD

View Poster Contact Presenter

Poster Presenter

Authors

Richard Gale, Dilsher S Dhoot, Maximilian Pfau, Sunir Garg, David Lally, Allen Hu, Andrew Chang, Laurentino Biccas, Nicole Eter, Jennifer Arnold, Chao Li, Felix Yemanyi, Michael Friedman, Caroline R Baumal, Charles C Wykoff

Affiliations

Hull York Medical School, University of York, Heslington, UK, California Retina Consultants/Retina Consultants of America, Santa Barbara, CA, USA,

Part of Topic

Medical retina

Earlier Treatment Yields Better Outcomes: 5 Years of Pegcetacoplan Treatment for Geographic Atrophy Secondary to AMD

Geographic Atrophy (GA), Pegcetacoplan, Open-label extension, 5-year data, neovascular age-related macular degeneration (nAMD)

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

University of Bonn, Bonn, Germany,

MidAtlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA,

New England Retina Consultants, Springfield, MA, USA,

Cumberland Valley Retina Consultants, Hagerstown, MD, USA,

Sydney Retina, Sydney, Australia; The Save Sight Institute, The University of Sydney, Discipline of Ophthalmology, Sydney Medical School, Sydney, Australia; University of New South Wales, Sydney, Australia,

Ocular Oftalmologia, Vitória, Espírito Santo, Brazil,

University of Münster, Münster, Germany,

Marsden Eye Specialists, Parramatta, NSW, Australia,

Apellis Pharmaceuticals, Waltham, MA, USA,

Apellis Pharmaceuticals, Waltham, MA, USA; Retina Specialists of Boston and Wellesley, Wellesley, MA, USA,

Retina Consultants of Texas, Houston, TX, USA; Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

Other ePosters in

Topic

P12912-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in P...

P13012-month real-world outcomes of switching to aflibercept 8 mg in subopti...

P1312-year real-world outcomes�from the use of Faricimab in neovascular�age-...

P132A Comparative Audit of Faricimab (Vabysmo) versus Aflibercept (Eylea) in...

P133A Novel Ophthalmic Stent Concept to Improve Choroidal Perfusion in Geogr...

ePosters in

Topics

Audit and clinical governance(27)Case reports(34)Cataract and refractive surgery(16)Cornea and ocular surface(13)Emergency ophthalmology(9)Glaucoma(27)Medical retina(79)Miscellaneous(26)Neuro ophthalmology(8)Orbit and oculoplastics(6)